Market Bizzz

Deepak Shenoy, Founder of Capital Mind, shares his insights on the current market scenario. He observes that while there has been some FII selling, the market decline is not a major concern. He remains optimistic about specific sectors like defense and manufacturing, while exercising caution in areas like NBFCs and microfinance.

Sun Pharma faces a delay in the U.S. launch of its drug Leqselvi due to a preliminary injunction by the New Jersey court, pending further legal proceedings or patent expiration in December 2026. The company plans to appeal the decision while considering a potential settlement with Incyte.

Afcons Infrastructure is set to debut its shares on the stock exchanges this Monday, with a grey market premium (GMP) of Rs 15 indicating a potential listing price of Rs 478, reflecting a 3% premium over the upper issue price of Rs 463.

Sunil Singhania from Abakkus Asset Manager talks about investing in stocks with realistic return expectations over longer periods. He highlights opportunities in sectors like financials, pharma, infra-related, and capex-related areas. Singhania advises caution in overvalued theme-based sectors and sees potential in renewable energy, discretionary consumption, and the impact of transitioning to lower fossil fuel dependence.

For 15 years they have not done anything. You just imagine even Hong Kong index was some 32,000 or 34,000 in 2008. It is still hovering around 22,000 or 20,000 or something and 14 years and we are I do not know eight times plus or nine times plus we do not know

Amid weak market sentiment, small and midcap stocks performed strongly, with WPIL Ltd shares climbing 44.16% in a week. Other notable gainers include Prudent Corporate Advisory Services, AMI Organics, and Syrma SGS Technology. Midcap stocks like Gillette India and Indian Bank also surged, reflecting robust growth in these segments.

The Nifty largely consolidated with a bearish undertone over the past five sessions, trading within a narrow range and ending the week with a modest gain. The index stayed below its crucial resistance points and saw increased volatility. Looking forward, careful approach is advised as technical rebounds are likely to face resistance.

Other so-called Magnificent Seven members Meta Platforms and Microsoft also reported earnings earlier this week and warned on AI-related infrastructure costs, dragging the Nasdaq down on Thursday.

Nifty gained 24.47% in Samvat 2080—the second-best in a decade—yet most experts anticipate moderate returns of 5-10% in the new year.